AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Biome Grow Inc.

$0 -$0.00 (-0.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0 - $0
Market Cap
56.21K
AVG Volume
8.4K
Trailing/Forward PE
-0.01/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
2026-11-30
Primary Exchange
Other OTCUS
Revenue (CAD)
00.250.50.75121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BIOIF Revenue (CAD) by quarter
PeriodRevenue (CAD)
23 Q30
23 Q20
23 Q10
22 Q40
22 Q30
22 Q20
22 Q10
21 Q40
21 Q30
21 Q20
Net Income (CAD)
-15M-10M-5M05M21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BIOIF Net Income (CAD) by quarter
PeriodNet Income (CAD)
23 Q3-195K
23 Q253.16K
23 Q1-264K
22 Q4-1.73M
22 Q3-599K
22 Q2-4.54M
22 Q1-4.02M
21 Q4-863K
21 Q3-4.04M
21 Q2-12.55M
Operating Income (CAD)
-800K-600K-400K-200K021 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BIOIF Operating Income (CAD) by quarter
PeriodOperating Income (CAD)
23 Q3-123K
23 Q2-185.77K
23 Q1-160K
22 Q4-298K
22 Q3-112K
22 Q2-119K
22 Q1-108K
21 Q4-697K
21 Q3-112K
21 Q2-168K
EBITDA (CAD)
-15M-10M-5M021 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BIOIF EBITDA (CAD) by quarter
PeriodEBITDA (CAD)
23 Q3-24.38K
23 Q2-140.15K
23 Q1-160K
22 Q4-1.39M
22 Q3-112K
22 Q2-4.33M
22 Q1-3.82M
21 Q4-77.81K
21 Q3-3.82M
21 Q2-12.28M
Cash Flows (CAD)
-1.5M-1M-500K021 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BIOIF Cash Flows (CAD) by quarter
PeriodCash Flows (CAD)
23 Q3-16
23 Q2-98.82K
23 Q1-153.38K
22 Q4-40.12K
22 Q3-100.32K
22 Q2-348.23K
22 Q1-254K
21 Q4-1.24M
21 Q3-74.2K
21 Q2-225.44K
EPS (CAD)
-0.15-0.1-0.05-00.0521 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BIOIF EPS (CAD) by quarter
PeriodEPS (CAD)
23 Q3-0
23 Q20
23 Q1-0
22 Q4-0.02
22 Q3-0.01
22 Q2-0.04
22 Q1-0.04
21 Q4-0.01
21 Q3-0.04
21 Q2-0.11
Expenses (CAD)
0200K400K600K800KR&DSG&ACapex21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BIOIF Expenses (CAD) by quarter
PeriodExpenses (CAD)
23 Q3110.62K
23 Q2185.77K
23 Q1145.06K
22 Q4292.93K
22 Q3102.88K
22 Q2110.83K
22 Q1103.01K
21 Q4674.19K
21 Q3101.46K
21 Q2159.19K
Cash & Debt (CAD)
05M10M15M20MCashLong Term DebtShort Term Debt21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BIOIF Cash & Debt (CAD) by quarter
PeriodCash & Debt (CAD)
23 Q356.36K
23 Q2147.25K
23 Q1212.38K
22 Q4332.43K
22 Q31.14M
22 Q21.81M
22 Q16.77M
21 Q49.41M
21 Q312.25M
21 Q216.14M
Debt ratios
-6-4-20221 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BIOIF Debt ratios by quarter
PeriodDebt ratios
23 Q3-2.41
23 Q2-2.25
23 Q1-0.67
22 Q4-0.4
22 Q3-0.28
22 Q2-0.14
22 Q10.16
21 Q4-4.45
21 Q3-1.34
21 Q2-2.05
Margins
-600%-400%-200%0%200%18 Q219 Q119 Q219 Q319 Q420 Q120 Q2
BIOIF Margins by quarter
PeriodMargins
20 Q225.12%
20 Q112.6%
19 Q4-18.45%
19 Q343.05%
19 Q244.1%
19 Q160.02%
18 Q2-600%
Return on Capital
-200%-100%0%100%200%300%21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BIOIF Return on Capital by quarter
PeriodReturn on Capital
23 Q34.05%
23 Q2-1.15%
23 Q15.64%
22 Q439.06%
22 Q322.2%
22 Q2215.23%
22 Q1-166.49%
21 Q4-13.42%
21 Q3-55.47%
21 Q2-110.95%
Shares Outstanding
050M100M150M21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BIOIF Shares Outstanding by quarter
PeriodShares Outstanding
23 Q3112.44M
23 Q2112.42M
23 Q1112.42M
22 Q4112.42M
22 Q3112.42M
22 Q2112.42M
22 Q1112.42M
21 Q4112.42M
21 Q3112.42M
21 Q2112.42M
Book Value Per Share (CAD)
-0.0500.050.10.1521 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BIOIF Book Value Per Share (CAD) by quarter
PeriodBook Value Per Share (CAD)
23 Q3-0.04
23 Q2-0.04
23 Q1-0.04
22 Q4-0.04
22 Q3-0.02
22 Q2-0.02
22 Q10.02
21 Q40.06
21 Q30.06
21 Q20.1
Total Assets (CAD)
05M10M15M20M21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BIOIF Total Assets (CAD) by quarter
PeriodTotal Assets (CAD)
23 Q3130.28K
23 Q2220.67K
23 Q1366.8K
22 Q4462.66K
22 Q31.73M
22 Q22.46M
22 Q17.06M
21 Q411.07M
21 Q312.95M
21 Q216.84M
PE Ratio
0.20.40.60.81med 0.58Jul 21Aug 21Oct 21Nov 21Dec 21Feb 22Mar 22
BIOIF PE Ratio by quarter
PeriodPE Ratio
Mar 220.54
Mar 220.58
Mar 220.68
Mar 220.71
Feb 220.64
Feb 220.58
Feb 220.85
Feb 220.56
Jan 220.54
Jan 220.76
Jan 220.89
Jan 220.7
Dec 210.64
Dec 210.66
Dec 210.66
Dec 210.71
Dec 210.52
Nov 210.59
Nov 210.56
Nov 210.72
Nov 210.56
Oct 210.61
Oct 210.71
Oct 210.71
Oct 210.77
Oct 210.71
Sep 210.26
Sep 210.32
Sep 210.31
Sep 210.32
Aug 210.37
Aug 210.37
Aug 210.4
Aug 210.54
Jul 210.41
Jul 210.48
Jul 210.37
Jul 210.34
Jul 210.36
Free Cash Flow Yield
-400%-300%-200%-100%0%med -373.93%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
BIOIF Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-374.92%
Sep 26-375.93%
Aug 26-374.04%
Aug 26-377.8%
Aug 26-374.82%
Aug 26-373.12%
Jul 26-371.1%
Jul 26-368.99%
Jul 26-370.89%
Jul 26-367.46%
Jul 26-366.67%
Jun 26-366.5%
Jun 26-367.81%
Jun 26-371.74%
Jun 26-373.08%
May 26-377.15%
May 26-376.39%
May 26-378.31%
May 26-380.26%
May 26-382.74%
Apr 26-380.51%
Apr 26-379.86%
Apr 26-375.73%
Apr 26-373.6%
Mar 26-374.35%
Mar 26-379.03%
Mar 26-378.98%
Mar 26-383.48%
Feb 26-381.28%
Feb 26-380.29%
Feb 26-381.95%
Feb 26-380.38%
Jan 26-381.89%
Jan 26-379.64%
Jan 26-373.72%
Jan 26-373.81%
Jan 26-378.78%
Dec 25-380.35%
Dec 25-376.9%
Dec 25-377.62%
Dec 25-376.4%
Nov 25-372.2%
Nov 25-368.86%
Nov 25-370.92%
Nov 25-370.22%
Oct 25-371.37%
Oct 25-371.6%
Oct 25-370.96%
Oct 25-371.52%
Oct 25-372.9%
Sep 25-373.06%
Sep 25-377.57%
Sep 25-375.61%
Sep 25-376.15%
Aug 25-378.5%
Aug 25-376.24%
Aug 25-376.41%
Aug 25-378.05%
Aug 25-377.15%
Jul 25-379.62%
Jul 25-379.04%
Jul 25-379.97%
Jul 25-382.85%
Jun 25-380.17%
Jun 25-378.66%
Jun 25-382.96%
Jun 25-379.88%
May 25-378.58%
May 25-378.79%
May 25-372.34%
May 25-373.28%
May 25-376.47%
Apr 25-375.5%
Apr 25-375.91%
Apr 25-375.09%
Apr 25-365.53%
Mar 25-363.33%
Mar 25-362.38%
Mar 25-361.88%
Mar 25-362.07%
Feb 25-359.64%
Feb 25-365.8%
Feb 25-366.72%
Feb 25-364%
Jan 25-358.06%
Jan 25-362.63%
Jan 25-359.15%
Jan 25-94.92%
Jan 25-94.75%
Dec 24-24.38%
Dec 24-47.61%
Dec 24-48.09%
Dec 24-48.35%
Nov 24-48.87%
Nov 24-48.97%
Nov 24-24.95%
Nov 24-49.21%
Nov 24-49.07%
Oct 24-16%
Oct 24-50.93%
Price to Sales
0246med 1.84Mar 20Jun 20Sep 20Dec 20Mar 21Jun 21Sep 21
BIOIF Price to Sales by quarter
PeriodPrice to Sales
Sep 212.2
Sep 212.7
Sep 212.63
Sep 212.7
Aug 213.15
Aug 213.16
Aug 213.39
Aug 214.56
Jul 213.46
Jul 214.03
Jul 213.15
Jul 212.87
Jul 213.07
Jun 212.02
Jun 212
Jun 212.29
Jun 212.15
May 212.22
May 211.96
May 212.12
May 212.33
Apr 212.14
Apr 212.48
Apr 212.48
Apr 212.42
Apr 212.41
Mar 211.3
Mar 211.47
Mar 211.44
Mar 211.67
Feb 211.84
Feb 211.93
Feb 211.93
Feb 211.9
Jan 211.29
Jan 211.29
Jan 210.95
Jan 210.86
Dec 200.89
Dec 200.89
Dec 200.7
Dec 200.77
Dec 200.56
Nov 200.49
Nov 200.53
Nov 200.49
Nov 200.49
Oct 200.65
Oct 200.73
Oct 200.65
Oct 200.69
Oct 200.72
Sep 200.86
Sep 201.37
Sep 201.45
Sep 200.93
Aug 200.93
Aug 201.18
Aug 201.32
Aug 201.29
Jul 201.55
Jul 201.43
Jul 201.65
Jul 201.22
Jul 200.86
Jun 201.73
Jun 201.52
Jun 201.69
Jun 201.95
May 202.69
May 202.34
May 201.84
May 201.59
May 201.8
Apr 201.64
Apr 201.22
Apr 201.29
Apr 201.35
Mar 202.04
Mar 201.64
Mar 201.95
Mar 202.35
Feb 202.59
Feb 202.8
Feb 203.1
Feb 203.39
Jan 204.07
Jan 204.61
Jan 205.07
Jan 204.61
Jan 205.05
EV/EBITDA
-50510med -0.99Apr 21Jul 21Sep 21Nov 21Feb 22Apr 22Jun 22
BIOIF EV/EBITDA by quarter
PeriodEV/EBITDA
Jun 22-2.7
Jun 22-2.68
Jun 22-2.29
Jun 22-2.32
May 22-1.87
May 22-1.85
May 22-2.78
May 22-1.44
Apr 22-2.09
Apr 22-2.12
Apr 22-1.22
Apr 22-1.28
Apr 22-1.27
Mar 22-0.87
Mar 22-0.83
Mar 22-0.74
Mar 22-0.72
Feb 22-0.78
Feb 22-0.83
Feb 22-0.59
Feb 22-0.85
Jan 22-0.86
Jan 22-0.67
Jan 22-0.56
Jan 22-0.73
Dec 21-0.78
Dec 21-1.32
Dec 21-1.31
Dec 21-1.26
Dec 21-1.47
Nov 21-1.39
Nov 21-1.43
Nov 21-1.25
Nov 21-1.43
Oct 21-1.37
Oct 21-1.26
Oct 21-1.26
Oct 21-1.2
Oct 21-1.26
Sep 21-1.1
Sep 21-1.04
Sep 21-1.05
Sep 21-1.04
Aug 21-0.99
Aug 21-0.99
Aug 21-0.96
Aug 21-0.81
Jul 21-0.95
Jul 21-0.88
Jul 21-0.99
Jul 21-1.02
Jul 21-1
Jun 211.62
Jun 211.35
Jun 215.41
Jun 213.48
May 214.38
May 210.78
May 213.11
May 216.01
Apr 213.37
Apr 218.07
Apr 218.13
Apr 217.18
Apr 217.09
Price/Operating Cashflow
510152025med 15.56Dec 20Jan 21Jan 21Feb 21Feb 21Mar 21Mar 21
BIOIF Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Mar 2114.01
Mar 2115.83
Mar 2115.56
Mar 2118.03
Feb 2119.88
Feb 2120.78
Feb 2120.8
Feb 2120.47
Jan 2113.9
Jan 2113.92
Jan 2110.23
Jan 219.27
Dec 209.58
Price to Book
02468med 0.64Dec 20Apr 21Jul 21Nov 21Feb 22Jun 22Sep 22
BIOIF Price to Book by quarter
PeriodPrice to Book
Sep 220.77
Sep 220.62
Sep 220.61
Sep 221.1
Aug 221.09
Aug 221.15
Aug 220.67
Aug 220.76
Jul 220.56
Jul 220.73
Jul 221.35
Jul 221.08
Jul 221.13
Jun 220.36
Jun 220.36
Jun 220.45
Jun 220.44
May 220.53
May 220.54
May 220.35
May 220.62
Apr 220.49
Apr 220.48
Apr 220.67
Apr 220.66
Apr 220.66
Mar 220.42
Mar 220.45
Mar 220.53
Mar 220.55
Feb 220.5
Feb 220.45
Feb 220.67
Feb 220.44
Jan 220.43
Jan 220.6
Jan 220.7
Jan 220.55
Dec 210.5
Dec 210.4
Dec 210.4
Dec 210.43
Dec 210.32
Nov 210.36
Nov 210.34
Nov 210.44
Nov 210.34
Oct 210.37
Oct 210.43
Oct 210.43
Oct 210.47
Oct 210.43
Sep 210.21
Sep 210.25
Sep 210.25
Sep 210.25
Aug 210.3
Aug 210.3
Aug 210.32
Aug 210.43
Jul 210.33
Jul 210.38
Jul 210.3
Jul 210.27
Jul 210.29
Jun 211.23
Jun 211.22
Jun 211.39
Jun 211.31
May 211.35
May 211.19
May 211.29
May 211.42
Apr 211.31
Apr 211.51
Apr 211.51
Apr 211.47
Apr 211.47
Mar 214.76
Mar 215.38
Mar 215.29
Mar 216.13
Feb 216.76
Feb 217.06
Feb 217.07
Feb 216.96
Jan 214.72
Jan 214.73
Jan 213.48
Jan 213.15
Dec 203.25
Dec 201.43
Dec 201.13
Dec 201.24
Dec 200.9
Nov 200.79
Nov 200.85
Nov 200.78
Nov 200.78
Oct 201.05
Biome Grow Inc.
BIOIF
Stockpicker

Video analysis: BIOIF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.